Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027221
Filing Date
2021-05-13
Accepted
2021-05-13 07:44:24
Documents
66
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q freq-10q_20210331.htm 10-Q 1940262
2 EX-31.1 freq-ex311_6.htm EX-31.1 20268
3 EX-31.2 freq-ex312_7.htm EX-31.2 20236
4 EX-32.1 freq-ex321_8.htm EX-32.1 9770
5 EX-32.2 freq-ex322_10.htm EX-32.2 9795
  Complete submission text file 0001564590-21-027221.txt   5532724

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT freq-20210331.xml EX-101.INS 873540
7 XBRL TAXONOMY EXTENSION SCHEMA freq-20210331.xsd EX-101.SCH 43696
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE freq-20210331_cal.xml EX-101.CAL 35662
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE freq-20210331_def.xml EX-101.DEF 148285
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20210331_lab.xml EX-101.LAB 368225
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20210331_pre.xml EX-101.PRE 272923
Mailing Address 19 PRESIDENTIAL WAY, SUITE 203 WOBURN MA 01801
Business Address 19 PRESIDENTIAL WAY, SUITE 203 WOBURN MA 01801 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39062 | Film No.: 21917240
SIC: 2834 Pharmaceutical Preparations